RARA CRAFT DATABASE for FDA Medical Devices
510(k)K153229

FDA DEVICE FACTS

Superbium

Bios S.R.L.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEApril 12, 2016PRODUCT CODEGEX

Indications for use

The Nd:Yag 1064 Laser Handpiece (Long Pulsed) is intended for: -treatment of benign vascular lesions such as but not limited to, port wine stains, hemangiomas , telangiectasias, rosacea, venus lake, facial and leg veins; -treatment of benign pigmented lesions such as, but not limited to, senile lentigines (age spots), solar lentigos (sun spots), pigmented seborrheic keratoses, nevi, chloasma , cafe-au-lait macules , and plaques; -tattoos (significant reduction in the int ensity of black and/or blue-black tattoos); verrucae, skin tag s,seborrheic keratosis;

- reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar;

- coagulation and hemostasis of soft tissue; -the removal of unwanted hair for skin types I-VI, and to effect stable long-term permanent hair reduction. Permanent reduction in hair regrowth is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The Nd:Yag 1064 Laser Handpiece (Short Pulsed) is intended for: Removal of tattoos and blemishes of the skin, the treatment of various pigmentation lesions Laser skin treatment procedures for the treatment of: Acne scars, Wrinkles The Nd:YAG Q-Switched Handpieces (1 064 nm) are indicated for treatment of:

- Benign vascular lesions such as, but not limited to treatment of: Port wine stains ; Hemangiomas; Warts; Superficial and deep telangiectasias (venulectasias); Reticular veins (0.1-4.0 mm dia.) of the leg; Rosacea; Venus lake ; Leg veins; Spider veins; Poikiloderma of Civatte; Angiomas -Benign cutaneous lesions, such as, but not limited to: Warts; Scars; Striae; Psoriasis -Benign pigmented lesions such as , but not limited to: Lentigos (age spots); Solar lentigos (sun spots); Cafe-au-lait macules; Se borrheic keratoses; Nevi and nevus of Ota; Chloasma; Verrucae; Skin tags ; Keratoses; The removal of black, blue or green tattoos (significant reduction in the intensity of black and /or blue/black tattoos); Plaques

- Pigmented benign lesions to reduce lesion size, for pa tients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments.

- The non-ablative treatment of facial wrinkles , such as, but not limited to: Periocular wrinkles; Perioral wrinkles; -Laser skin resurfacing procedures for the treatment of: Acne scars; Wrinkles

- Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. -Indicated for use on all skin types (Fitzpatrick I-VI), including tanned skin. The Nd:YAG Q-Switched Handpieces (5 32 nm) are indicated for treatment of: -Incision, excision, ablation, vaporization of soft tissue.

- Tattoo removal: Light blue; Yellow; Red ; Green -Vascular lesions: Hemangiomas (Port wine stains /birthmarks, cavernous, cherry, spider, hemangiomas); Angiomas (cherry, spider); Telangiectasia; Spider nevi -Benign pigmented lesions: Cafe-au-lait (macules) ; Lentigines (senile and solar); Freckles (ephelides) ; Chloasma; Nevi; Nevus spillus; Nevus ofOta ;Becker's Nevi -Other benign pigmented cutaneous lesions: Verrucae ; Skin tags; Keratoses; Plaques The 2940 nm Er:YAG Laser Module handpiece is indicated for: Coagulation, vaporization, ablation or cutting of soft tissu e (skin) in Dermatology, Plastic Surgery, Oral Surgery, ENT, Gynecology, General Surgery , Podiatry and Ophthalmology (skin around the eyes). Laser skin resurfacing procedures for the treatment of:

•A c n e scars  Wrinkles The 2940 nm Er:Yag Fractional tips are indicated for: Use in soft tissue (skin , cutaneous tissue, subcutaneous tissue , striated and smooth tissue , muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes; organs, and glands) such as, but not limited to: Dermatology and plastic Surgery: Sk in resurfacing Treatment of wrinkles ; Epidermal nevi ; Telangiectasia; Spider veins; Actinic chelitis; Keloids; Verrucae; Skin tags; Anal tags; Keratoses; Scar revision (including acne scars). The 1540 Fractional Non-ablative Laser Handpiece is intended for use in coagulation of soft tissue , skin resurfacing procedures as well as treatment of melasma, striae , acne scars and surgical scars. IPL 400-1200 run handpiece is indicated for:  The treatment of moderate inflammatory acne vulgaris.  The treatment of benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles).  The treatment of benign cuta neous lesions including warts , scars and striae.  The treatment of benign cutaneous vascular lesions includi ng port wine stains, hemangi omas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea , angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. Use on all skin types (Fitzpatrick I-VI). IPL500-1200 nm handpiece is indicated for:  The treatment of moderate inflammatory acne (acne vulgaris).  The treatment of tattoos and benign pigmented epid ermal and cutaneous lesions including warts, scars, striae, dyschromia, hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, melasma, and cafe..au-lait macules.  The treatment of benign cutaneous vascular lesions includi ng port wine stains, hemangi omas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea , angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations.  The removal of unwanted hair to effect stable long-term or permanent hair reduction. Permanent reduction in hair regrowth is defined as the long-term , stable reduction in the number of hairs regrowing when measured at 6, 9 , and 12 months after the completion of a treatment regime. Use on Fitzpatrick skin types I-V. IPL 550-1200 nm handpiece is indicated for:  The treatment of moderate inflammatory acne Vulgans.  The treatment of benign pigmented epidermal lesions , including dyschromia, hyperpigmentation, melasma and ephelides (freckles).  The treatment of face and body vascular and pigmented lesions.  The treatment of cutaneous lesions , including scars and striae.  The treatment of benign cutaneous vascular lesions , including port wine stains , hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations.  The removal of unwanted hair to effect stable long-term or permanent hair reduction. Permanent reduction in hair regrowth is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime.  Use on all skin types (Fitzpatrick I-VI). IPL 580-1200 run handpiece is indicated for:  The treatment of moderate inflammatory acne vulgaris.  The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma and ephelides (freckles).  The treatment of face and body vascular and pigmented lesions.  The treatment of cutaneous l esions, including scars and striae.  The treatment of benign cutaneous vascular lesions , including port wine stains , hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas , poikiloderma of Civatte, leg veins and venous malformations.  The removal of unwanted hair to effect stable long-term or permanent hair reduction. Permanent reduction in hair regrowth is defined as the long-term , stable reduction in the number of hairs regrowing when measured at 6, 9 , and 12 months after the completion of a treatment regime.  Use on all skin types (Fitzpatrick I-VI). IPL 620-1200 nm handpiece is indicated for:  The treatment of tattoos.  The treatment of moderate inflammatory acne vulgaris.  The treatment of benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles), lentigines, nevi, melasma, and cafe-au-lait.  The treatment of cutaneous les ions including warts, scars and striae.  The treatment of benign cutaneous vascular lesions includi ng port wine stains, hemangi omas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea , angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. : The removal of unwanted hair and to effect stable long-term or permanent hair reduction. Permanent reduction in hair regrowth is defined as the long-term , stable reduction in the number of hairs regrowing when measured at 6, 9 , and 12 months after the completion of a treatment regime.  Use on all skin types (Fitzpatrick I-VI), including tanned skin. IPL 755-1200 nm handpiece is indicated for:  The treatment of tattoos.  The treatment of moderate inflammatory acne vulgaris.  The treatment of benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles).  The treatment of cutaneous les ions including warts, scars and striae.  The treatment of benign cutaneous vascular le sions including port wine stains, hemangiomas , facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider a ngiomas, poikiloderma of Civatte, leg veins and venous malformations.  The treatment of psoriasis , vitiligo, atopic dermatitis (eczema), seborrheic dermatitis.  The treatment of pseudofolliculitis barbae (PFB).  The removal of unwanted hair to effect stable long-term or permanent hair reduction. Permanent reduction in hair regrowth is defined as the long-term , stable reduction in the number of hairs regrowing when measured at 6, 9 , and 12 months after the completion of a treatment regime. Use on all skin types (Fitzpatrick I-VI) , including tanned skin.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 3, 2026